Premium
Real‐world variability in dabigatran levels in patients with atrial fibrillation: comment
Author(s) -
Douxfils J.,
Chatelain B.,
Dogné J.M.,
Mullier F.
Publication year - 2015
Publication title -
journal of thrombosis and haemostasis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.947
H-Index - 178
eISSN - 1538-7836
pISSN - 1538-7933
DOI - 10.1111/jth.12880
Subject(s) - dabigatran , atrial fibrillation , medicine , cardiology , warfarin
J . DOUXF I LS ,* B . CHATELA IN ,† J . -M . DOGN E* and F . MULL I ER† *Department of Pharmacy, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for LIfe Sciences (NARILIS), University of Namur, Namur; and †Hematology Laboratory, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for LIfe Sciences (NARILIS), CHU DinantGodinne UcL Namur, Universit e Catholique de Louvain, Yvoir, Belgium